- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-alcoholic Fatty Liver Disease in New Zealand
Total 4543 results
-
Arrowhead PharmaceuticalsCompletedNon-alcoholic SteatohepatitisNew Zealand
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis NASHUnited Kingdom, United States, Australia, New Zealand, Switzerland, Jordan, Georgia, Puerto Rico
-
Northwell HealthCompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Enanta Pharmaceuticals, IncICON Clinical Research; Triangle BiostatisticsCompletedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, New Zealand, Canada, France, Puerto Rico
-
Weill Medical College of Cornell UniversityRecruitingNon-Alcoholic Fatty Liver DiseaseUnited States
-
Columbia UniversityGlaxoSmithKlineCompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
GenMont Biotech IncorporationFu Jen Catholic University HospitalRecruitingNon-Alcoholic Fatty Liver DiseaseTaiwan
-
Institute of Liver and Biliary Sciences, IndiaWithdrawnNon Alcoholic SteatohepatitisIndia
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon Alcoholic SteatohepatitisIndia
-
Meridian Bioscience, Inc.CompletedNon-Alcoholic SteatohepatitisUnited States, France, Belgium, United Kingdom
-
GenfitTerminatedNon Alcoholic SteatohepatitisUnited States
-
Hepanova Inc.UnknownNon-Alcoholic Steatohepatitis (NASH)United States
-
Fu Jen Catholic University HospitalEnrolling by invitationNon-alcoholic Fatty Liver DiseaseTaiwan
-
Institute of Liver and Biliary Sciences, IndiaUnknownNon Alcoholic SteatohepatitisIndia
-
NeuroBo Pharmaceuticals Inc.RecruitingNON-ALCOHOLIC STEATOHEPATITISUnited States
-
Institute of Liver and Biliary Sciences, IndiaWithdrawnNon Alcoholic SteatohepatitisIndia
-
PfizerCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited States
-
Immuron Ltd.CompletedNon-alcoholic Steatohepatitis (NASH)United States, Australia, Israel
-
Enanta Pharmaceuticals, IncTerminatedNon-Alcoholic SteatohepatitisUnited States, Canada, Puerto Rico, United Kingdom, Argentina, Germany
-
Institute of Liver and Biliary Sciences, IndiaUnknownNon-Alcoholic Fatty Liver DiseaseIndia
-
Rockefeller UniversityNational Institutes of Health (NIH); Weill Medical College of Cornell UniversityCompletedObesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Mochida Pharmaceutical Company, Ltd.CompletedSteatohepatitisUnited States, Puerto Rico
-
Madrigal Pharmaceuticals, Inc.UnknownNon-alcoholic SteatohepatitisUnited States
-
PfizerCompletedLiver Fibrosis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
PfizerCompletedNon-Alcoholic Fatty Liver Disease (NAFLD)United States
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon-alcoholic SteatohepatitisIndia
-
Rivus Pharmaceuticals, Inc.RecruitingFatty Liver | Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis (NASH)Belgium, Germany, Taiwan, Austria, United States, Spain, Korea, Republic of, Argentina, Australia, Italy, Japan, Singapore, Netherlands, Slovakia, France, Canada, India
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States, New Zealand
-
Northwell HealthWithdrawnNon-alcoholic Fatty Liver Disease (NAFLD)United States
-
Fibronostics USA, IncCompletedNon-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Liver Inflammation | Liver Fibroses | Liver SteatosesUnited States
-
Novo Nordisk A/SActive, not recruitingNon-alcoholic SteatohepatitisSpain, Denmark, Taiwan, Korea, Republic of, Australia, Canada, India, Singapore, United States, Turkey, Poland, Italy, Belgium, Puerto Rico, United Kingdom, Malaysia, Germany, Portugal, Bulgaria, Czechia, France, Greece, Japan, Russian...
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisUnited States, France
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
PfizerCompletedNon-alcoholic Fatty Liver DiseaseUnited States
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Novo Nordisk A/SRecruitingNon-alcoholic SteatohepatitisUnited States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Switzerland, Ireland, Belgium, Romania, Ger... and more
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Taiwan, Netherlands, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
GenfitPremier Research Group plc; NaturalphaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
-
Genentech, Inc.TerminatedNon-alcoholic SteatohepatitisBelgium, United States, Spain, Puerto Rico, France
-
Mirum Pharmaceuticals, Inc.TerminatedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, Canada, Puerto Rico
-
PfizerCompleted
-
Northwell HealthTerminatedNon-Alcoholic Fatty Liver Disease | Probiotics MeSH Descriptor Data 2018 | Interleukin-17 MeSH Descriptor Data 2018United States
-
Institute of Liver and Biliary Sciences, IndiaRecruitingMetabolic Syndrome | Non-Alcoholic Fatty Liver DiseaseIndia
-
Cirius Therapeutics, Inc.Chiltern International Inc.CompletedNon-alcoholic Fatty Liver Disease | NASH - Nonalcoholic Steatohepatitis | Non-alcoholic SteatohepatitisUnited States
-
Institute of Liver and Biliary Sciences, IndiaCompletedLiver CirrhosisIndia
-
AstraZenecaCompletedNon-cirrhotic Non-alcoholic Steatohepatitis With FibrosisUnited States, Austria, Italy, Thailand, Germany, Korea, Republic of, Japan, Malaysia, New Zealand, Spain, Taiwan, Turkey, Australia, Israel, Argentina, Canada, Greece, South Africa, United Kingdom, France
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
Conatus Pharmaceuticals Inc.CompletedLiver Diseases | Fibrosis | Non-alcoholic SteatohepatitisUnited States, Spain, Germany